Challenges and strategies for rare diseases trials

Less than 3% of rare diseases clinical trials include investigational sites in India, which is much lower than the figures for prevalent chronic diseases

Related Keywords

India , ,Trial Landscape ,Pharma Intelligence ,Rare Diseases Clinical ,Rare Patient Voice ,Rare Diseases ,Chronic Diseases ,Clinical Trials ,